Pharma Focus Asia

Roche and Hitachi High-Tech Extend Their 46-Year Collaboration, Enabling Further Progress in Diagnostic Testing

Monday, May 27, 2024

Roche and Hitachi High-Tech have recently announced a significant extension of their partnership, committing to at least another decade of collaboration. This renewed commitment strengthens their joint efforts in advancing diagnostic innovation, engineering, and manufacturing, further solidifying their longstanding relationship.

Over the years, their combined expertise has led to remarkable advancements in in-vitro diagnostic solutions. From pioneering the world's first multi-channel analyzer to automating immunology processes, their collaboration has consistently pushed boundaries, enabling healthcare systems to better serve patients' needs.

Roche Diagnostic Solutions, expressed his enthusiasm, highlighting the impact of this agreement on medical technology and patient care. Similarly, Taku Sakazume, Executive Officer of Hitachi High-Tech Corporation, emphasized the companies' shared commitment to driving innovation in the global diagnostics market.

With over 84,000 diagnostic platforms installed worldwide, the partnership facilitates the performance of more than 21 billion tests annually. This renewed agreement is expected to further accelerate the delivery of new tests and technologies while enhancing efficiency and accuracy through automated processes.

Exciting innovations, such as the cobas® c 703 and cobas® ISE neo analytical units, are set to be introduced later this year, expanding testing capacity and improving diagnosis accuracy for millions of patients globally. Additionally, the upcoming cobas® Mass Spec solution will integrate fully-automated mass spectrometry into routine lab procedures, offering gold standard technology across various clinical applications.

These innovations are reshaping diagnostic practices, driving sustainability, and fortifying health systems worldwide. The renewed partnership underscores Roche and Hitachi High-Tech's shared vision of leveraging technology to address healthcare challenges and improve lives.

Roche and Hitachi High-Tech have collaborated to deliver innovative diagnostics worldwide. Their partnership has not only led to groundbreaking testing solutions but has also prioritized sustainability efforts, reducing plastic waste by up to 80 percent with new generation systems.

Both companies remain dedicated to driving innovation in in-vitro diagnostics to tackle present and future healthcare challenges.



Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024